Impact of molecular sequence data completeness on HIV cluster detection and a network science approach to enhance detection.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 11 2022
Historique:
received: 28 03 2022
accepted: 05 10 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Detection of viral transmission clusters using molecular epidemiology is critical to the response pillar of the Ending the HIV Epidemic initiative. Here, we studied whether inference with an incomplete dataset would influence the accuracy of the reconstructed molecular transmission network. We analyzed viral sequence data available from ~ 13,000 individuals with diagnosed HIV (2012-2019) from Houston Health Department surveillance data with 53% completeness (n = 6852 individuals with sequences). We extracted random subsamples and compared the resulting reconstructed networks versus the full-size network. Increasing simulated completeness was associated with an increase in the number of detected clusters. We also subsampled based on the network node influence in the transmission of the virus where we measured Expected Force (ExF) for each node in the network. We simulated the removal of nodes with the highest and then lowest ExF from the full dataset and discovered that 4.7% and 60% of priority clusters were detected respectively. These results highlight the non-uniform impact of capturing high influence nodes in identifying transmission clusters. Although increasing sequence reporting completeness is the way to fully detect HIV transmission patterns, reaching high completeness has remained challenging in the real world. Hence, we suggest taking a network science approach to enhance performance of molecular cluster detection, augmented by node influence information.

Identifiants

pubmed: 36357480
doi: 10.1038/s41598-022-21924-8
pii: 10.1038/s41598-022-21924-8
pmc: PMC9648870
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

19230

Subventions

Organisme : CDC HHS
ID : NU62PS924515
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI135992
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Kidney Res Clin Pract. 2017 Mar;36(1):3-11
pubmed: 28392994
Int J Emerg Med. 2021 Apr 14;14(1):22
pubmed: 33853518
J Infect Dis. 2006 Sep 15;194 Suppl 1:S51-8
pubmed: 16921473
AIDS. 2003 May 2;17(7):1063-9
pubmed: 12700457
J Biomed Inform. 2008 Feb;41(1):1-14
pubmed: 17625974
Science. 2009 Jul 24;325(5939):412-3
pubmed: 19628854
AIDS Res Hum Retroviruses. 2019 Apr;35(4):368-375
pubmed: 30403157
Sci Rep. 2019 Jan 31;9(1):1051
pubmed: 30705307
J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):428-35
pubmed: 26258569
Stat Methods Med Res. 2006 Jun;15(3):213-34
pubmed: 16768297
Viruses. 2021 Mar 30;13(4):
pubmed: 33808053
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):543-550
pubmed: 30222659
Sci Rep. 2021 Feb 8;11(1):3325
pubmed: 33558579
Am J Prev Med. 2021 Nov;61(5 Suppl 1):S130-S142
pubmed: 34686282
Sci Rep. 2015 Mar 02;5:8665
pubmed: 25727453
J Infect Dis. 2005 Sep 15;192(6):958-66
pubmed: 16107947
Lancet HIV. 2019 Jun;6(6):e382-e395
pubmed: 31036482
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
Sex Transm Dis. 2018 Apr;45(4):222-228
pubmed: 29465708
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
Mol Biol Evol. 2018 Jul 1;35(7):1812-1819
pubmed: 29401317
MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):344-349
pubmed: 30998671

Auteurs

Sepideh Mazrouee (S)

Department of Medicine, University of California San Diego, San Diego, CA, USA. smazrouee@ucsd.edu.

Camden J Hallmark (CJ)

Houston Health Department, Houston, TX, USA.

Ricardo Mora (R)

Houston Health Department, Houston, TX, USA.

Natascha Del Vecchio (N)

Department of Medicine, University of Chicago, Chicago, IL, USA.

Rocio Carrasco Hernandez (R)

Department of Medicine, University of California San Diego, San Diego, CA, USA.
Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, México.

Michelle Carr (M)

Houston Health Department, Houston, TX, USA.

Marlene McNeese (M)

Houston Health Department, Houston, TX, USA.

Kayo Fujimoto (K)

Department of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Joel O Wertheim (JO)

Department of Medicine, University of California San Diego, San Diego, CA, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH